BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11166001)

  • 1. Aspirin: new cardiovascular uses for an old drug.
    Patrono C
    Am J Med; 2001 Jan; 110(1A):62S-65S. PubMed ID: 11166001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative antiplatelet activity of COX1 NSAIDS versus aspirin, encompassing regimen simplification and gastroprotection: a call for a controlled study.
    Rothschild BM
    Reumatismo; 2004; 56(2):89-93. PubMed ID: 15309216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
    Hohlfeld T; Saxena A; Schrör K
    Thromb Haemost; 2013 May; 109(5):825-33. PubMed ID: 23238666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
    Patrono C
    Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin in cardiovascular disorders. What is the optimum dose?
    Kong DF
    Am J Cardiovasc Drugs; 2004; 4(3):151-8. PubMed ID: 15134467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin and cyclooxygenase-2 inhibitors.
    Armstrong TA
    Am J Health Syst Pharm; 2003 Jul; 60(14):1481. PubMed ID: 12892035
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin revisited: helpful or harmful? What is the correct dose for a certain population?
    Drown DJ
    Prog Cardiovasc Nurs; 2008; 23(1):49-50. PubMed ID: 18326997
    [No Abstract]   [Full Text] [Related]  

  • 9. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
    Morini S; Zullo A
    G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
    Bethel MA; Harrison P; Sourij H; Sun Y; Tucker L; Kennedy I; White S; Hill L; Oulhaj A; Coleman RL; Holman RR
    Diabet Med; 2016 Feb; 33(2):224-30. PubMed ID: 26043186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
    Strand V
    Lancet; 2007 Dec; 370(9605):2138-51. PubMed ID: 18156036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.
    Harv Heart Lett; 2009 Jun; 19(10):4-5. PubMed ID: 19681207
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin and its rivals. As your options increase, your choices get harder.
    Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of damage induced by aspirin in the GI tract.
    Scheiman JM
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):153-62. PubMed ID: 22542153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term combination therapy with aspirin and clopidogrel.
    Kumana CR; Cheung G; Lauder IJ; Cheung BM
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):223-5. PubMed ID: 15678241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin therapy for cardiovascular disease.
    Goodnight SH
    Curr Opin Hematol; 1996 Sep; 3(5):355-60. PubMed ID: 9372101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin: old drug, new uses and challenges.
    Yeomans ND
    J Gastroenterol Hepatol; 2011 Mar; 26(3):426-31. PubMed ID: 21062358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.